Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few dis...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!